In leukemia patients with NPM1c, or rearrangements in KMT2A and NUP98, a number of these regulators are considered instrumental for loss of transcriptional control and aberrant expression of HOXA/B/MEIS1, and other leukemia-associated target genes. The gene discussed is MEIS1; the disease is leukemia.